Philadelphia Immediate Transport in Penetrating Trauma Trial

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

NCT00673439 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT

NCT06202625 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Optimal Platelet Dose Strategy for Management of Thrombocytopenia

NCT00128713 ·Status: COMPLETED ·Phase: PHASE3

Platelet Products Tested With the ThromboLUX® Platelet Quality Test

NCT02158416 ·Status: COMPLETED

Bleeding Prediction in Thrombocytopenia

NCT02306044 ·Status: COMPLETED

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829 ·Status: COMPLETED ·Phase: PHASE4

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075 ·Status: COMPLETED

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

NCT02851407 ·Status: COMPLETED ·Phase: PHASE3

Italian Platelet Technology Assessment Study

NCT01642563 ·Status: TERMINATED ·Phase: PHASE3

A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

NCT02137681 ·Status: WITHDRAWN ·Phase: PHASE3

rhTPO in Critical Patients With Thrombocytopenia

NCT02094248 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

NCT01443351 ·Status: WITHDRAWN

Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia

NCT02964325 ·Status: TERMINATED ·Phase: NA

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3

IVIg Plus Low Dose rhTPO for ITP in Pregnancy

NCT05634824 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

NCT01440361 ·Status: WITHDRAWN ·Phase: PHASE2

Strategies for Transfusion of Platelets (SToP)

NCT00420914 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

NCT03594045 ·Status: TERMINATED ·Phase: PHASE2

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

NCT00759083 ·Status: WITHDRAWN ·Phase: PHASE4

Defibrotide TMA Prophylaxis Pilot Trial

NCT03384693 ·Status: COMPLETED ·Phase: PHASE2

Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura

NCT00486421 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

NCT00922883 ·Status: COMPLETED ·Phase: PHASE2

Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)

NCT04931849 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

NCT04448184 ·Status: RECRUITING ·Phase: PHASE3

A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy

NCT02391272 ·Status: COMPLETED ·Phase: PHASE3